347 related articles for article (PubMed ID: 19075586)
1. Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration.
Sahara N; Maeda S; Takashima A
Curr Alzheimer Res; 2008 Dec; 5(6):591-8. PubMed ID: 19075586
[TBL] [Abstract][Full Text] [Related]
2. REVIEW: tau protein pathology in Alzheimer's disease and related disorders.
Tolnay M; Probst A
Neuropathol Appl Neurobiol; 1999 Jun; 25(3):171-87. PubMed ID: 10417659
[TBL] [Abstract][Full Text] [Related]
3. Nitration of tau protein is linked to neurodegeneration in tauopathies.
Horiguchi T; Uryu K; Giasson BI; Ischiropoulos H; LightFoot R; Bellmann C; Richter-Landsberg C; Lee VM; Trojanowski JQ
Am J Pathol; 2003 Sep; 163(3):1021-31. PubMed ID: 12937143
[TBL] [Abstract][Full Text] [Related]
4. The neuropathological spectrum of neurodegenerative tauopathies.
Tolnay M; Probst A
IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
[TBL] [Abstract][Full Text] [Related]
5. Tau-based treatment strategies in neurodegenerative diseases.
Schneider A; Mandelkow E
Neurotherapeutics; 2008 Jul; 5(3):443-57. PubMed ID: 18625456
[TBL] [Abstract][Full Text] [Related]
6. The role of tau phosphorylation and cleavage in neuronal cell death.
Chun W; Johnson GV
Front Biosci; 2007 Jan; 12():733-56. PubMed ID: 17127334
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.
Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L
FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794
[TBL] [Abstract][Full Text] [Related]
8. New insights into genetic and molecular mechanisms of brain degeneration in tauopathies.
Forman MS; Lee VM; Trojanowski JQ
J Chem Neuroanat; 2000 Dec; 20(3-4):225-44. PubMed ID: 11207421
[TBL] [Abstract][Full Text] [Related]
9. Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.
Williams DR
Intern Med J; 2006 Oct; 36(10):652-60. PubMed ID: 16958643
[TBL] [Abstract][Full Text] [Related]
10. Tau-RNA complexes inhibit microtubule polymerization and drive disease-relevant conformation change.
McMillan PJ; Benbow SJ; Uhrich R; Saxton A; Baum M; Strovas T; Wheeler JM; Baker J; Liachko NF; Keene CD; Latimer CS; Kraemer BC
Brain; 2023 Aug; 146(8):3206-3220. PubMed ID: 36732296
[TBL] [Abstract][Full Text] [Related]
11. Mutations causing neurodegenerative tauopathies.
Goedert M; Jakes R
Biochim Biophys Acta; 2005 Jan; 1739(2-3):240-50. PubMed ID: 15615642
[TBL] [Abstract][Full Text] [Related]
12. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
Goedert M
Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
[TBL] [Abstract][Full Text] [Related]
13. [Neuroprotective treatment of tauopathies].
Respondek G; Krey L; Huber M; Pflugrad H; Wegner F; Höglinger GU
Nervenarzt; 2021 Dec; 92(12):1227-1238. PubMed ID: 34652482
[TBL] [Abstract][Full Text] [Related]
14. Tau protein pathology in neurodegenerative diseases.
Spillantini MG; Goedert M
Trends Neurosci; 1998 Oct; 21(10):428-33. PubMed ID: 9786340
[TBL] [Abstract][Full Text] [Related]
15. Untangling the tauopathies: Current concepts of tau pathology and neurodegeneration.
Ling H
Parkinsonism Relat Disord; 2018 Jan; 46 Suppl 1():S34-S38. PubMed ID: 28789904
[TBL] [Abstract][Full Text] [Related]
16. Neurodegenerative tauopathies.
Lee VM; Goedert M; Trojanowski JQ
Annu Rev Neurosci; 2001; 24():1121-59. PubMed ID: 11520930
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Disease and other Tauopathies: Exploring Efficacy of Medicinal Plant-derived Compounds in Alleviating Tau-mediated Neurodegeneration.
Durairajan SSK; Selvarasu K; Bera MR; Rajaram K; Iyaswamy A; Li M
Curr Mol Pharmacol; 2022; 15(2):361-379. PubMed ID: 34488602
[TBL] [Abstract][Full Text] [Related]
18. Tauopathies and tau oligomers.
Takashima A
J Alzheimers Dis; 2013; 37(3):565-8. PubMed ID: 23948895
[TBL] [Abstract][Full Text] [Related]
19. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
[TBL] [Abstract][Full Text] [Related]
20. Grape derived polyphenols attenuate tau neuropathology in a mouse model of Alzheimer's disease.
Wang J; Santa-Maria I; Ho L; Ksiezak-Reding H; Ono K; Teplow DB; Pasinetti GM
J Alzheimers Dis; 2010; 22(2):653-61. PubMed ID: 20858961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
